Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping

使用表位靶向 DNA 甲基化作图的超灵敏多组学平台

• 批准号: 10622310
• 负责人: Michael-Christopher Keogh
• 金额: $ 10.36万
• 依托单位: EPICYPHER, INC.
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-02-01 至 2023-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10622310
• 关键词: Address; Award; Bioinformatics; Businesses; DNA Methylation; Eligibility Determination; Employee; Epitopes; Funding Opportunities; Goals; Grant; Individual; Leadership; National Human Genome Research Institute; Research; Role; Science; Scientist; Small Business Innovation Research Grant; System; Talents; Time; United States National Institutes of Health; Validation; Woman; career development; multiple omics

Candidate Eligibility Statement The goal of this diversity supplement application is to provide career development support for Dr. Allison Hickman, a bioinformatician who aspires to (and with support could perform) leadership roles in commercial science. Women have been under-represented in science leadership, particularly in the field of bioinformatics, and this award would formally address the issue by supporting a truly talented individual. Dr. Hickman is a US citizen and full-time employee at EpiCypher Inc., a Small Business Concern (SBC) eligible to submit applications to the National Institutes of Health. EpiCypher was recently awarded an SBIR Fast-Track Grant from NHGRI [R44 HG011875] that is currently in year one (of three) and is eligible for diversity supplement support. 5.12.2022 Dr. Allison Hickman - Diversity Supplement Candidate (Research Scientist) Date 5.11.2022 Dr. Martis Cowles - EpiCypher Signing Official (Chief Business Officer) Date

候选人资格声明